Pacific Biosciences (PACB) Jumps: Stock Moves 8.3% Higher - Tale of the Tape


Shutterstock photo

Pacific Biosciences of California, Inc. ( PACB ) was a big mover last session with its shares rising over 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend of the company, as the stock has lost over 9% in the past one-month time frame.

This biotechnology company has seen no estimate revision in the last 7 days. The Zacks Consensus Estimate hasn't been in trend either. Yesterday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Pacific Biosciences currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked Med-Drug stocks include Natus Medical Inc. ( BABY ), AngioDynamics Inc. ( ANGO ) and Cyberonics Inc. ( CYBX ). While BABY sports a Zacks Rank #1 (Strong Buy), ANGO and CYBX carry a Zacks Rank #2 (Buy).  

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

ANGIODYNAMICS (ANGO): Free Stock Analysis Report

NATUS MEDICAL (BABY): Free Stock Analysis Report

CYBERONICS INC (CYBX): Free Stock Analysis Report

PACIFIC BIOSCI (PACB): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: Investing , Investing Ideas , Stocks
More Headlines for: ANGO , BABY , CYBX , PACB

More from


Equity Research
Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by